Table 1.
Main clinical, ultrasonographic, and laboratory data for patients with NAFLD and control subjects
| Variable | NAFLD | Control | P value |
|---|---|---|---|
| Number | 250 | 85 | |
| Sex (M) | 139 | 46 | 0.9 |
| Age (years) | 46.58 (±10.4) | 44.85 (±14.17) | 0.028 |
| Weight (kg) | 83.90 (±9.53) | 70.3 (±11.27) | 0.001 |
| BMI (kg/m2) | 29.88 (±3.88) | 25.29 (±4.19) | 0.001 |
| ALT | 30.10 (±33.47) | 19.82 (±11.98) | 0.006 |
| AST | 37.23 (±26.64) | 22.29 (±10.73) | 0.001 |
| TG (mg/dL) | 189.14 (±88.1) | 107.05 (±36.97) | 0.001 |
| Total cholesterol (mg/dL) | 207.71 (±49.81) | 163.83 (±34.50) | 0.001 |
| HDL (mg/L) | 41.05 (±8.62) | 52.69 (±9.03) | 0.001 |
| MPV (fL) | 10.51 (±2.86) | 9.10 (±1.12) | 0.001 |
| CRP (+) | 22.4% | 3.5% | 0.001 |
| HTN (+) | 40.8% | 15.2% | 0.001 |
| Plaque (+) | 20% | 11.7% | 0.176 |
| FBS (mg/L) | 117.16 (±61.52) | 90.77 (±15.10) | 0.001 |
| IMT (mm) | 0.81(±0.14) | 0.58 (±0.15) | 0.001 |
Abbreviations: BMI, body mass index; TG, triglycerides; HDL, high-density lipoprotein; CRP, C-reactive protein; HTN, hypertension; FBS, fasting blood glucose; IMT, intima-media thickness; MPV, mean platelet volume; ALT, alanine aminotransferase; AST, aspartate aminotransferase; NAFLD, nonalcoholic fatty liver disease.